Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
International Journal of Molecular Sciences - Switzerland
doi 10.3390/ijms20174235
Full Text
Open PDFAbstract
Available in full text
Categories
Date
August 29, 2019
Authors
Unknown
Publisher
MDPI AG